37. Any other disease, metabolic dysfunction, physical examination finding, or clinical laboratory finding that lead to reasonable suspicion of a disease or condition that contraindicates the use of an investigational drug, may affect the interpretation of the results, or may render the participant at high risk for treatment complications.